Gynecologic and Obstetric Investigation
Case Report
Salpingectomy for Unilateral Hydrosalpinx May Improve in vivo FecundityChoe J. · Check J.H.Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Camden, N.J., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: December 01, 1999
Issue release date: November 1999
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Abstract
The objective of this study was to determine whether unilateral salpingectomy for hydrosalpinx could improve fecundity in women with an apparently normal contralateral tube. Two women with unilateral hydrosalpinx and with an apparently normal contralateral tube, and a long history of infertility, including failure to conceive despite several cycles of in vitro fertilization (IVF), had unilateral salpingectomies prior to considering subsequent IVF cycles. Case 1 conceived after 1 month following surgery and case 2 after 8 months without the use of assisted reproductive technology. Though the ensuing pregnancies may have been fortuitous, the possibility exists that in cases of unilateral hydrosalpinx, the performance of salpingectomy may improve fecundity without the need for IVF. Hopefully the outcome of these 2 case reports may generate interest in a larger cooperative prospective study.
© 1999 S. Karger AG, Basel
Related Articles:
References
- Strandell A, Waldenstrom U, Nilsson L, Hamberger L: Hydrosalpinx reduces in vitro fertilization/embryo transfer pregnancy rate. Hum Reprod 1994;9:861–863.
- Blazar AS, Hogan JW, Seifer DB, Frishman GN, Wheeler CA, Haning RV: The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilization. Fertil Steril 1997;67:517–520.
- Vandromme J, Chasse E, Lejeune B, Van Rysselberge M, Selvigne A, Leroy F: Hydrosalpinges in in vitro fertilization: an unfavorable prognostic feature. Hum Reprod 1995;10:576–579.
- Andersen AN, Yue Z, Meng FJ, Petersen K: Low implantation rate after in vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod 1994;9:1935–1938.
- Fleming C, Hull MG: Impaired implantation after in vitro fertilization treatment associated with hydrosalpinx. Br J Obstet Gynaecol 1996;103:268–272.
- Katz E, Akman MA, Damewood MD, Garcia JE: Deleterious effect of in vitro fertilization. Fertil Steril 1996;66:122–125.
- Kassabji M, Sims JA, Butler L, Muasher SJ: Reduced pregnancy outcome in patients with unilateral or bilateral hydrosalpinx after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 1994;56:129–132.
-
Pie-Zeigler R, Shelton KE, Toner JP: Salpingectomy(ies) improves the pregnancy rate after IVF in patients with unilateral or bilateral hydrosalpinx. J Assist Reprod Genet 1995;12(suppl):65.
- Shelton KE, Butier L, Toner JP: Salpingectomy improves the pregnancy rate in in vitro fertilization patients with hydrosalpinx. Hum Reprod 1996;11:523–525.
- Puttemans PJ, Brosens IA: Salpingectomy improves in vitro fertilization outcome in patients with a hydrosalpinx: Blind victimization of the fallopian tube? Hum Reprod 1996;11:2079–2081.
- Aubriot FX, Chapron C, Morice P, Dubuisson JB: Hydrosalpinx et stérilité: Indications de la salpingectomie. Contracept Fertil Sex 1995;23:670–673.
- Andersen AN, Linhard A, Loft A, Ziebe S, Andersen CY: The infertile patient with hydrosalpinges: IVF with or without salpingectomy? Hum Reprod 1996;11:2081–2084.
- Dechaud H, Daures JP, Arnal F, Humeau C, Hedon B: Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study. Fertil Steril 1998;69:1020–1025.
- Shelton KE, Butler L, Toner JP, Oehninger S, Muasher SJ: Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx. Hum Reprod 1996;11:523–525.
- Mansour RT, Aboulghar MA, Sevour TI, Riad R: Fluid accumulation of the uterine cavity before embryo transfer: A possible hindrance for implantation. J In Vitro Fert Embryo Transfer 1991;8:157–159.
- Dubuisson JB, Aubriot FX, Mathieu L, Foulot H, Mandelbrot L, Bouquet de Joliniere J: Risk factors for ectopic pregnancy in 556 pregnancies after in vitro fertilization: Implications for preventive management. Fertil Steril 1991;56:686–690.
- Wainer R, Camus E, Camier B, Martin C, Vasseur C, Merlet F: Does hydrosalpinx reduce the pregnancy rate after in vitro fertilization? Fertil Steril 1997;68:1022–1026.
Article / Publication Details
Published online: December 01, 1999
Issue release date: November 1999
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
